Cognitive behavioural therapy for the treatment of chronic fatigue syndrome in adults - a meta-analysis.
Kolala, Vivek, La Rosa, Billie, Vangaveti, Venkat et al. · Frontiers in psychiatry · 2025 · DOI
Quick Summary
This review looked at 12 studies involving nearly 1,800 people with ME/CFS to see if cognitive behavioural therapy (CBT)—a type of talking therapy that focuses on thoughts and behaviours—helps reduce fatigue and improve daily functioning. The results were mixed: one-on-one CBT showed promise for reducing fatigue, and self-directed CBT (doing it yourself with materials) helped some people function better physically. However, group CBT and other forms didn't show clear benefits. No serious harms were reported, but the quality of evidence was limited by inconsistent reporting across studies.
Why It Matters
This systematic review synthesizes current evidence on a commonly recommended treatment for ME/CFS, helping patients and clinicians make informed decisions about whether CBT might be appropriate. The differentiation between CBT modalities (individual, self-directed, group) provides practical guidance on which approaches may be most beneficial for different patient presentations. The findings contribute to ongoing debate about ME/CFS treatment guidelines and highlight the need for higher-quality, better-reported studies.
Observed Findings
Individual face-to-face CBT showed a large effect size for fatigue reduction (Cohen's d = 2.91, p=0.02)
Self-directed CBT showed a large effect size for improving physical functioning (Cohen's d = -2.76, p=0.04)
When all CBT modalities were combined, no statistically significant effect on fatigue was found (p = 0.12)
No serious adverse effects were reported across the 12 studies, though reporting was inconsistent
Secondary outcomes (anxiety, depression, pain, quality of life) showed no significant benefits across CBT modalities
Inferred Conclusions
CBT efficacy in ME/CFS is highly dependent on the modality used, with face-to-face and self-directed approaches showing greater promise than group-based interventions
Patients with milder disease may derive greater benefit from self-directed CBT compared to those with more severe presentations
CBT should be offered as a supportive, non-curative treatment option rather than as primary disease-modifying therapy
Current guideline recommendations for CBT in ME/CFS reflect genuine uncertainty in the evidence base
Remaining Questions
What specific patient characteristics (disease severity, symptom profile, psychological factors) predict which individuals will respond to CBT and which modality?
What This Study Does Not Prove
This meta-analysis does not prove that CBT cures or substantially treats ME/CFS as a whole—the authors explicitly note it should be considered only as a supportive, non-curative option. The mixed results and high heterogeneity mean we cannot definitively establish which patients will benefit most or why some forms work better than others. The inconsistent reporting of adverse effects means we cannot fully characterize potential harms, and the inability to blind participants inherently introduces bias that may inflate treatment effects.
Tags
Symptom:Cognitive DysfunctionPainFatigue
Method Flag:PEM Not DefinedWeak Case DefinitionMixed Cohort
Why does face-to-face CBT show fatigue benefits while self-directed CBT benefits physical functioning—are these measuring different aspects of recovery?
How do adverse effects of CBT in ME/CFS compare to other treatment modalities, and why was adverse event reporting so inconsistent?
Can future studies with improved blinding methods, standardized outcome measures, and complete adverse event reporting clarify whether observed effects are real or attributable to bias and expectancy effects?